New Targets for Zika Virus Determined by Human-Viral Interactomic: A Bioinformatics Approach
- PMID: 29379794
- PMCID: PMC5742907
- DOI: 10.1155/2017/1734151
New Targets for Zika Virus Determined by Human-Viral Interactomic: A Bioinformatics Approach
Abstract
Identifying ZIKV factors interfering with human host pathways represents a major challenge in understanding ZIKV tropism and pathogenesis. The integration of proteomic, gene expression and Protein-Protein Interactions (PPIs) established between ZIKV and human host proteins predicted by the OralInt algorithm identified 1898 interactions with medium or high score (≥0.7). Targets implicated in vesicular traffic and docking were identified. New receptors involved in endocytosis pathways as ZIKV entry targets, using both clathrin-dependent (17 receptors) and independent (10 receptors) pathways, are described. New targets used by the ZIKV to undermine the host's antiviral immune response are proposed based on predicted interactions established between the virus and host cell receptors and/or proteins with an effector or signaling role in the immune response such as IFN receptors and TLR. Complement and cytokines are proposed as extracellular potential interacting partners of the secreted form of NS1 ZIKV protein. Altogether, in this article, 18 new human targets for structural and nonstructural ZIKV proteins are proposed. These results are of great relevance for the understanding of viral pathogenesis and consequently the development of preventive (vaccines) and therapeutic targets for ZIKV infection management.
Figures
Similar articles
-
Zika Virus: Immune Evasion Mechanisms, Currently Available Therapeutic Regimens, and Vaccines.Viral Immunol. 2017 Dec;30(10):682-690. doi: 10.1089/vim.2017.0046. Epub 2017 Oct 13. Viral Immunol. 2017. PMID: 29028178 Review.
-
Potential targets for therapeutic intervention and structure based vaccine design against Zika virus.Eur J Med Chem. 2018 Aug 5;156:444-460. doi: 10.1016/j.ejmech.2018.07.014. Epub 2018 Jul 10. Eur J Med Chem. 2018. PMID: 30015077 Review.
-
Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.J Virol. 2017 Sep 27;91(20):e00834-17. doi: 10.1128/JVI.00834-17. Print 2017 Oct 15. J Virol. 2017. PMID: 28794019 Free PMC article.
-
[Advances in Zika vaccines].Wei Sheng Wu Xue Bao. 2017 Feb 4;57(2):188-96. Wei Sheng Wu Xue Bao. 2017. PMID: 29750481 Review. Chinese.
-
A DNA Vaccine Protects Human Immune Cells against Zika Virus Infection in Humanized Mice.EBioMedicine. 2017 Nov;25:87-94. doi: 10.1016/j.ebiom.2017.10.006. Epub 2017 Oct 6. EBioMedicine. 2017. PMID: 29033368 Free PMC article.
Cited by
-
Amyloid precursor protein is a restriction factor that protects against Zika virus infection in mammalian brains.J Biol Chem. 2020 Dec 11;295(50):17114-17127. doi: 10.1074/jbc.RA120.015165. Epub 2020 Oct 7. J Biol Chem. 2020. PMID: 33028637 Free PMC article.
-
The Neurobiology of Zika Virus: New Models, New Challenges.Front Neurosci. 2021 Mar 29;15:654078. doi: 10.3389/fnins.2021.654078. eCollection 2021. Front Neurosci. 2021. PMID: 33897363 Free PMC article. Review.
-
INMI1 Zika Virus NS4B Antagonizes the Interferon Signaling by Suppressing STAT1 Phosphorylation.Viruses. 2021 Dec 6;13(12):2448. doi: 10.3390/v13122448. Viruses. 2021. PMID: 34960717 Free PMC article.
-
In silico predictions of protein interactions between Zika virus and human host.PeerJ. 2021 Aug 24;9:e11770. doi: 10.7717/peerj.11770. eCollection 2021. PeerJ. 2021. PMID: 34513323 Free PMC article.
-
Autophagy in Zika Virus Infection: A Possible Therapeutic Target to Counteract Viral Replication.Int J Mol Sci. 2019 Feb 28;20(5):1048. doi: 10.3390/ijms20051048. Int J Mol Sci. 2019. PMID: 30823365 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical